Trial · NCT04287387
Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents
NCT04287387, Phase 4, Unknown, Peking Union Medical College Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents. Trials, record NCT04287387. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04287387
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents
- NCT number
- NCT04287387
- Status
- Unknown
- Phases
- Phase 4
- Enrollment
- 180 participants, estimated
- Lead sponsor
- Peking Union Medical College Hospital
- Conditions
- Type2 Diabetes Mellitus
- Interventions
- Glucophage 500Mg Tablet, Acarbose Tablets, Sitagliptin tablet, Dapagliflozin Tablet, Pioglitazone Tablets, Glimepiride Tablets
- First posted
- 2020-02-27
- Last updated
- 2020-02-27
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes from baseline to post-treatment in composition in gut microbiota analyzed by meta-genome sequencing. | Baseline, Week 4, Week 8, Week 12 | |
| Primary | Changes from baseline to post-treatment in composition in fasting blood glucose. | Baseline, Week 4, Week 8, Week 12 | |
| Primary | Changes from baseline to post-treatment in composition in level of TNF-a. | Baseline, Week 4, Week 8, Week 12 | |
| Primary | Changes from baseline to post-treatment in composition in fasting insulin. | Baseline, Week 4, Week 8, Week 12 | |
| Primary | Changes from baseline to post-treatment in blood lipid including cholesterol, triglycerides, high-density lipoprotein. | Baseline, Week 4, Week 8, Week 12 | |
| Primary | Changes from baseline to post-treatment in composition in 2-hour postprandial blood glucose. | Baseline, Week 4, Week 8, Week 12 | |
| Primary | Changes from baseline to post-treatment in composition in level of IL-6. | Baseline, Week 4, Week 8, Week 12 | |
| Primary | Changes from baseline to post-treatment in composition in level of IL-8. | Baseline, Week 4, Week 8, Week 12 | |
| Primary | Changes from baseline to post-treatment in composition in level of IL-10. | Baseline, Week 4, Week 8, Week 12 | |
| Primary | Changes from baseline to post-treatment in composition in level of C-reative protein. | Baseline, Week 4, Week 8, Week 12 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04287387
GET https://conductscience.org/api/trials/v1/NCT04287387/registered